United States In-Vitro Diagnostics Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global In-Vitro Diagnostics market reached US$ 84.90 billion in 2024 and is expected to reach US$ 131.68 billion by 2032, growing at a CAGR of 5.0% during the forecast period 2025-2032.

Key Development:

United States: Recent IVD Launches, Investments & Developments

✅ September 2025: Insight Molecular Diagnostics unveiled a novel molecular test kit GraftAssureTM for kidney transplant rejection detection using donor-derived cell-free DNA (dd-cfDNA). The innovation aims to enhance precision and reduce the need for invasive biopsies.

✅ May 2025: Roche announced a $550 million investment to expand its Indianapolis diagnostics hub into a continuous glucose monitoring (CGM) manufacturing center. The project strengthens domestic production capacity for diabetes care devices.

✅ May 2025: Siemens Healthineers committed $150 million to expand U.S. manufacturing and modernize facilities. The initiative includes relocating Varian production to Palo Alto and enhancing diagnostic technology supply-chain resilience.

Japan: Recent IVD Launches, Investments & Developments

✅ September 2025: PHC Corporation (IVD division) and JCR received the 2025 Kids Design Award for their automated injection device GROWJECTOR® L. The product reflects Japan's growing emphasis on patient-friendly diagnostic solutions.

✅ July 2025: Shionogi launched the MIC Dry Plate Cefiderocol to assess bacterial susceptibility to Fetroja, advancing targeted antibiotic diagnostics and antimicrobial stewardship.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/in-vitro-diagnostics-market?sb

Recent Mergers and Acquisitions:

United States: Recent IVD Mergers & Acquisitions

✅ July 2025: Waters Corporation announced a merger with Becton, Dickinson & Company's Biosciences & Diagnostic Solutions division in a $17.5 billion deal. The integration will expand Waters' footprint in clinical diagnostics and enhance its infectious disease and oncology testing portfolio.

✅ July 2025: Advanced Instruments, a subsidiary of Patricia Industries, completed the acquisition of Nova Biomedical for $2.2 billion. The merger creates a stronger life sciences tools platform, combining analytical instruments and consumables for biopharma and clinical markets.

Japan: Recent IVD Mergers & Acquisitions

✅ October 2025: Tokuyama Corporation completed the acquisition of JSR Corporation's in-vitro diagnostics and diagnostic materials business. The transaction establishes a new entity to strengthen Tokuyama's position in advanced medical diagnostics and life sciences materials.

Key Players:

=> BioMerieux, Becton, Dickinson and Company, Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc, Abbott Laboratories, Qiagen NV, FUJIFILM Holdings Corporation, Sysmex Corporation and Siemens Healthineers AG among others.

Growth Forecast Projected:

The Global In-Vitro Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global In-Vitro Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=in-vitro-diagnostics-market

Key Segments:

➥ By Product Type: Instruments, Reagents, Software and Services, Others

➥ By Technique Type: Immunoassays, POC Diagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics, Microbiology, Self-Blood-Glucose Monitoring, Others

➥ By Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, Others

➥ By End-User: Diagnostic Laboratories, Hospitals, Academics and Research Institutes, Others

Regional Analysis for In-Vitro Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among In-Vitro Diagnostics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze In-Vitro Diagnostics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/in-vitro-diagnostics-market?sb

FAQ

What is the current size of the In-Vitro Diagnostics Market?

A: In 2024, the In-Vitro Diagnostics Market was valued at US$ 84.90 billion , reflecting its strong industry presence.

Q2: How large is the In-Vitro Diagnostics Market expected to be by 2032?

A: By 2032, industry forecasts suggest the In-Vitro Diagnostics Market will grow to around US$ 131.68 billion, demonstrating significant expansion.

Q3: What is the growth rate of the In-Vitro Diagnostics Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.0% during the forecast period from 2025 to 2032.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.